MRC1 and neoplasm: This shift in macrophage populations, characterized by an increase in pro-inflammatory M1 macrophages (MCP-1 +, CD80 +, and iNOS +) and a decrease in immunosuppressive M2 macrophages (CD206 +), suggests that the triple combination treatment effectively reprogrammed the tumor microenvironment toward an immunostimulatory state.